Publications by authors named "Jules Russick"

Natural killer (NK) cells play a pivotal role against cancer, both by direct killing of malignant cells and by promoting adaptive immune response though cytokine and chemokine secretion. In the lung tumor microenvironment (TME), NK cells are scarce and dysfunctional. By conducting single-cell transcriptomic analysis of lung tumors, and exploring pseudotime, we uncovered that the intratumoral maturation trajectory of NK cells is disrupted in a tumor stage-dependent manner, ultimately resulting in the selective exclusion of the cytotoxic subset.

View Article and Find Full Text PDF
Article Synopsis
  • 4-cresol, a substance linked to health benefits in diabetes, enhances insulin sensitivity in mouse myoblasts and boosts insulin secretion in isolated mouse islets.
  • The compound demonstrates minimal off-target effects and binds primarily to specific kinases like RPS6KA3, which are important in pancreatic islet function.
  • Research indicates that 4-cresol may improve glycemic control and β-cell activity, highlighting its potential role in diabetes treatment.
View Article and Find Full Text PDF

One billion people worldwide get flu every year, including patients with non-small cell lung cancer (NSCLC). However, the impact of acute influenza A virus (IAV) infection on the composition of the tumor microenvironment (TME) and the clinical outcome of patients with NSCLC is largely unknown. We set out to understand how IAV load impacts cancer growth and modifies cellular and molecular players in the TME.

View Article and Find Full Text PDF

SARS-CoV-2 infection leads to a highly variable clinical evolution, ranging from asymptomatic to severe disease with acute respiratory distress syndrome, requiring intensive care units (ICU) admission. The optimal management of hospitalized patients has become a worldwide concern and identification of immune biomarkers predictive of the clinical outcome for hospitalized patients remains a major challenge. Immunophenotyping and transcriptomic analysis of hospitalized COVID-19 patients at admission allow identifying the two categories of patients.

View Article and Find Full Text PDF

The complement system plays a complex role in cancer. In clear cell renal cell carcinoma (ccRCC), local production of complement proteins drives tumor progression, but the mechanisms by which they do this are poorly understood. We found that complement activation, as reflected by high plasma C4d or as C4d deposits at the tumor site, was associated with poor prognosis in two cohorts of patients with ccRCC.

View Article and Find Full Text PDF

To investigate the mechanisms underlying the SARS-CoV-2 infection severity observed in patients with obesity, we performed a prospective study of 51 patients evaluating the impact of multiple immune parameters during 2 weeks after admission, on vital organs' functions according to body mass index (BMI) categories. High-dimensional flow cytometric characterization of immune cell subsets was performed at admission, 30 systemic cytokines/chemokines levels were sequentially measured, thirteen endothelial markers were determined at admission and at the zenith of the cytokines. Computed tomography scans on admission were quantified for lung damage and hepatic steatosis (n = 23).

View Article and Find Full Text PDF
Article Synopsis
  • A 75-year-old patient with cervical lymphadenopathy exhibited symptoms of acquired hemophilia A (AHA), including elevated aPTT and low factor VIII (FVIII) levels, with high anti-FVIII antibodies detected.
  • Histological analysis revealed benign follicular hyperplasia and elevated serum IgG4 levels, indicating the presence of IgG4-related disease (IgG4-RD).
  • The patient was treated successfully with prednisone and rituximab, leading to an exploration of the connection between AHA and IgG4-RD, eventually determining that specific anti-FVIII autoantibodies were predominantly IgG4 in subtype among cases with overlapping conditions.
View Article and Find Full Text PDF
Article Synopsis
  • NK cells in tumors are crucial for fighting cancer, but they can become dysfunctional in the tumor microenvironment (TME) due to inhibitory molecules.
  • The study analyzed gene expression in NK cells from human lung tumors and non-tumorous lung tissue to understand their inhibitory functions.
  • Findings revealed a specific gene signature indicating NK cell dysfunction in non-small cell lung carcinoma (NSCLC) and highlighted the role of certain receptors and proteins in impacting their effectiveness against tumors.
View Article and Find Full Text PDF

NK cells orchestrate the tumor destruction and control metastasis in a coordinated way with other immune cells of the tumor microenvironment. However, NK cell infiltration in the tumor microenvironment is limited, and tumor cells have developed numerous mechanisms to escape NK cell attack. As a result, NK cells that have been able to infiltrate the tumors are exhausted, and metabolically and functionally impaired.

View Article and Find Full Text PDF

The treatment or prevention of bleeding in patients with hemophilia A relies on replacement therapy with different factor VIII (FVIII)-containing products or on the use of by-passing agents, i.e., activated prothrombin complex concentrates or recombinant activated factor VII.

View Article and Find Full Text PDF

The lung offers one of the largest exchange surfaces of the individual with the elements of the environment. As a place of important interactions between self and non-self, the lung is richly endowed in various immune cells. As such, lung natural killer (NK) cells play major effector and immunoregulatory roles to ensure self-integrity.

View Article and Find Full Text PDF

The nitrone spin trap 5,5‑dimethyl‑1‑pyrroline N‑oxide (DMPO) dampens endotoxin-induced and TLR4-driven priming of macrophages, but the mechanism remains unknown. The available information suggests a direct binding of DMPO to the TIR domain, which is shared between TLRs. However, TLR2-TIR domain is the only TLR that have been crystallized.

View Article and Find Full Text PDF

Hemophilia A is a rare hemorrhagic disorder caused by the lack of functional pro-coagulant factor VIII. Factor VIII replacement therapy in patients with severe hemophilia A results in the development of inhibitory anti-factor VIII IgG in up to 30% of cases. To date, immune tolerance induction, with daily injection of large amounts of factor VIII, is the only strategy to eradicate factor VIII inhibitors.

View Article and Find Full Text PDF

The immunogenicity of therapeutic factor VIII (FVIII) in patients with hemophilia A has been puzzling scientific and clinical communities for more than 3 decades. Indeed, the development of inhibitory antibodies to FVIII remains a major clinical challenge and is associated with enormous societal costs. Thus, the reasons for which a presumably innocuous, short-lived, intravenously administered glycoprotein triggers such a deleterious, long-lasting neutralizing immune response is an enigma.

View Article and Find Full Text PDF